Figure 2From: Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experience Overall Survival median rate 13.3 months (95% CI 3.9 – 22.6); 6-month rate 63.9% (95% CI 29.3 – 85.0). Back to article page